Speech suddenly improves, 13 years after stroke, after perispinal etanercept

Rapid improvement in speech, aphasia, motor function and chronic post-stroke pain immediately following perispinal etanercept (PSE) treatment by Edward Tobinick M.D. Filmed January 2019 at the Institute of Neurological Recovery in Boca Raton, Florida. http://www.strokebreakthrough.com 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use


Improvement in minutes, 6 years after stroke, January 3, 2019 at the INR

Improvement in minutes, 6 years after stroke, following perispinal etanercept treatment by Edward Tobinick M.D. on January 3, 2019. Treatment at the Institute of Neurological Recovery in Boca Raton, FL. 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid neurological improvement 2.5 years after brain injury due to cardiac arrest following perispinal etanercept treatment

Rapid neurological improvement 2.5 years after brain injury due to cardiac arrest following perispinal etanercept treatment. Treatment by Edward Tobinick M.D. at the INR in Boca Raton, Florida. Filmed December 6, 2018, 4K version with subtitles. Text, images and video © 2019, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Multiple improvements after new stroke treatment, 18 years after stroke

Many rapid improvements 18 years after stroke. Treatment by Edward Tobinick M.D. at the INR in Boca Raton, Florida. Filmed November 29, 2018, 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Immediate improvement in chronic post-stroke pain 2 years after stroke at the INR, Boca Raton, November 20, 2018

Immediate improvement in chronic post-stroke pain 2 years after stroke. Treatment by Edward Tobinick, filmed November 20, 2018, at the INR in Boca Raton. 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Rapid improvement in speech, perception and pain, 3 yrs. after stroke

Immediate improvement in central post-stroke pain, 3 years after stroke, following perispinal etanercept. Treatment and filming Oct 31, 2018 and Nov 7, 2018, INR Boca Raton. 4K version, with subtitles. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

From Iceland, A Message of Hope

From Iceland, A Message of Hope. Perispinal Etanercept Treatment by Edward Tobinick M.D. at the INR Boca Raton enables return to work after stroke. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

Australian Government designates funds to advance Perispinal Etanercept stroke research in Australia

News Release, October 8, 2018: The Australian Government will invest $1 million to improve recovery and rehabilitation and help stroke survivors back to work. The Government package includes $750,000 specifically designated for funding a clinical trial of the innovative Perispinal Etanercept Stroke Treatment in Australia. “The project will enable more Australians of working age who have had a stroke to access new innovative and cutting edge treatment options to aid their recovery.”

Perispinal etanercept for treatment of chronic post-stroke neurological dysfunction is a treatment method invented and developed by Edward Tobinick M.D., Medical Director and Founder of the Institute of Neurological Recovery.

More at this link: http://www.health.gov.au/internet/ministers/publishing.nsf/Content/health-mediarel-yr2018-hunt134.htm

Australian Minister for Health Press Release announcing Perispinal Etanercept research support
The Hon Greg Hunt MP, Minister for Health, Australia

Thalamic syndrome improves 20 years after stroke following treatment at the INR, Sept. 2018

Improvement in neurological signs and symptoms of thalamic syndrome (Dejerine-Roussy Syndrome) due to a stroke 20 years previously (in 1998) after treatment at the Institute of Neurological Recovery in Boca Raton in September 2018, by Edward Tobinick, M.D. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today

Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use

From Denmark to the INR, September 2018, rapid recovery 5 years after stroke

Improvement in chronic intractable post-stroke sensory dysfunction in a 24 y.o. Danish woman, 5 years after stroke, within minutes after treatment at the Institute of Neurological Recovery in Boca Raton on September 21, 2018 by Edward Tobinick, M.D. Text, images and video © 2018, INR PLLC, all rights reserved.

Request a consultation today
Disclaimer: Individual results vary, not all patients respond. Additional doses may be necessary to maintain the clinical response. Treatment is innovative (“off-label”). Terms of Use